Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating whether adding Wobe-Mugos E to chemotherapy improves outcomes in stage II/III multiple myeloma; current status is…
-
CLINICAL_TRIALS research · 2013-12-18Clinical Trial Update: Beta Alethine in Treating Patients With Myeloma [Phase 1, Phase 2]
Clinical trial update on Beta Alethine for treating multiple myeloma and related plasma cell neoplasms, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) [Phase 2]
Phase 2 results for a combination of pegylated liposomal doxorubicin, low-frequency dexamethasone, and lenalidomide (Dd-R) in newly diagnose…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant [Phase 2]
This Phase 2 clinical trial update reports results for high-dose busulfan combined with bortezomib in high-risk multiple myeloma patients un…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation [Phase 1]
A Phase 1 dose-escalation study of denileukin diftitox (Ontak) given after autologous transplantation in multiple myeloma; the trial was ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating azacitidine for relapsed or refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
A terminated clinical trial studied T cells in blood and bone marrow from patients with multiple myeloma, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells [Phase 3]
Phase 3 trial evaluating whether prophylactic moxifloxacin after high-dose chemotherapy with peripheral stem cell transplantation reduces ba…
-
CLINICAL_TRIALS research · 2013-12-11Clinical Trial Update: Genomic-Based Diagnosis, Classification and Targeted Treatment of Multiple Myeloma
Clinical trial update describing genomic-based diagnosis, classification and targeted treatment approaches for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma [Phase 2]
Phase 2 results from a study of carfilzomib in relapsed and refractory multiple myeloma have been posted. The trial (NCT00511238) is complet…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated obatoclax with bortezomib for relapsed or refractory multiple myeloma. The study was terminated and res…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating chemotherapy given after GM-CSF for treating multiple myeloma; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-12-02Clinical Trial Update: A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT) [Phase 1]
This is a Phase 1 clinical trial evaluating JNJ-26866138 (bortezomib) in untreated multiple myeloma patients who are not candidates for hema…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy [Phase 2, Phase 3]
A Phase 2/Phase 3 trial in multiple myeloma compared thalidomide with dexamethasone against melphalan/prednisone for induction, and thalidom…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating bendamustine, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy [Phase 3]
Phase 3 trial comparing tandem high-dose melphalan with stem cell transplantation to triple intermediate-dose melphalan, and prednisolone/in…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma [Phase 1, Phase 2]
The update describes a Phase 1/2 trial evaluating a combination of Zarnestra (tipifarnib) with Velcade (bortezomib) for relapsed multiple my…
-
CLINICAL_TRIALS research · 2013-11-25Clinical Trial Update: Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure [Phase 2]
This Phase 2 study evaluates lenalidomide in combination with dexamethasone for treating patients with multiple myeloma who have light-chain…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant [Phase 1]
Phase 1 clinical trial update evaluating the use of bortezomib in multiple myeloma patients who have undergone autologous peripheral blood s…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma [Phase 1]
A Phase 1 study of MLN4924 (pevonedistat), a Nedd8-activating enzyme inhibitor, in adults with lymphoma or multiple myeloma has been complet…
-
FDA approval · 2013-11-15FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for POMALYST (pomalidomide) by Celgene Corporation, expanding its approved use. This confirms regula…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Prevention of Left Ventricular Dysfunction During Chemotherapy [Phase 3]
Phase 3 clinical trial update focusing on preventing left ventricular dysfunction during chemotherapy in patients with hematologic cancers.
-
CLINICAL_TRIALS research · 2013-11-14Clinical Trial Update: A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b [Phase 2]
This document provides an update on the Phase II trial protocol (SGL2001b) for ZIO-101 in advanced multiple myeloma and does not report tria…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 study evaluating the combination of bortezomib, ascorbic acid, and melphalan in newly diagnosed multiple myeloma patients. The trial…